Table 3.
Genotype and allele distributions of G501C in patients with cerebral infarction and controls
| Cases (%) | Control (%) | OR | 95% CI | P value | |
|---|---|---|---|---|---|
| Genotype |
|
|
|
|
|
| GG |
239 (61.9%) |
274 (71.0%) |
Reference |
|
|
| GC |
135 (35.0%) |
97 (25.1%) |
1.596 |
1.166-2.183 |
<0.01 |
| CC |
12 (3.1%) |
15 (3.9%) |
0.917 |
0.421-1.998 |
0.83 |
| Dominant effect |
|
|
|
|
|
| CC + GC vs GG |
147/239 |
112/274 |
1.505 |
1.114-2.033 |
<0.01 |
| Recessive effect |
|
|
|
|
|
| CC vs GC + GG |
12/374 |
15/371 |
0.794 |
0.367-1.718 |
0.56 |
| Allele |
|
|
|
|
|
| G |
613 (79.4%) |
645 (83.5%) |
Reference |
|
|
| C | 159 (20.6%) | 127 (16.5%) | 1.317 | 1.018-1.705 | 0.04 |
χ2 test is applied for calculation of P values.